ClinicalTrials.Veeva

Menu

Rota China Registry

Capital Medical University logo

Capital Medical University

Status

Completed

Conditions

Coronary Artery Disease

Treatments

Procedure: Rotational Atherectomy

Study type

Observational

Funder types

Other

Identifiers

NCT03806621
2017033

Details and patient eligibility

About

Rotational atherectomy (RA) facilitates percutaneous coronary intervention for complex de novo lesions with severe calcification. Some observational studies and a small randomized trial indicated that a strategy of routine RA did not conferred reduction in restenosis or MACE, but these studies are limited by missing follow-up, insufficient power to compare outcomes, and confounding factors in the RA group (long lesion length, etc.). With recent developments in medical therapy, advances in design and delivery of drug-eluting stents (DES), and advances in noninvasive and intravascular coronary imaging, the use of RA in current real-world practice remains to be well determined. We aimed to compile real-world clinical outcomes data for the RotablatorTM Rotational Atherectomy System in routine clinical practice in China.

Enrollment

980 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years old

  • Subject who is clinically indicated for PCI/stenting

  • Written informed consent

  • Subject is willing to comply with all protocol-required follow-up evaluation

  • Subject must meet one of following angiographic/procedural inclusion criteria:

    • Target lesion is moderately to severely calcified by visual estimate
    • Unsuccessful balloon dilatation of the target lesion
    • Unsuccessful passage of device(s) (microcatheter, balloon, or stent) across the target lesion

Exclusion criteria

  • Subject has clinical symptoms and/or electrocardiogram (ECG) changes consistent with acute MI within 2 weeks

  • Subject has any of the following angiographic findings:

    • Thrombus present in the target vessel (by visual estimate)
    • Significant dissection present in the target vessel (NHLBI types C-F)
    • Lesion angulation > 60°(by visual estimate)

Trial design

980 participants in 1 patient group

Rotational Atherectomy
Treatment:
Procedure: Rotational Atherectomy

Trial contacts and locations

19

Loading...

Central trial contact

Xiao Wang, MD; Shao-Ping Nie, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems